Patents by Inventor G. Lynn Howard

G. Lynn Howard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBLINGUAL EPINEPHRINE FORMULATIONS AND METHODS OF USE
    Publication number: 20230225994
    Abstract: The present disclosure provides epinephrine formulations and methods of treating anaphylaxis, methods for concomitant therapy during a cardiac event, methods for treating hypoglycemia, and a prophylactic method for immunotherapy, using the epinephrine formulations disclosed herein. The epinephrine formulations of the present disclosed are formulated for delivery via the oral mucosa. Epinephrine formulations of the present disclosure may further comprise citric acid to improve delivery of epinephrine through the oral mucosa. The epinephrine formulations of the present disclosure induce a robust, global sympathetic response in a subject that is disproportionate to the serum epinephrine concentration in the subject.
    Type: Application
    Filed: March 20, 2023
    Publication date: July 20, 2023
    Inventors: G. Lynn Howard, Nicholas J. Farina, Christopher Howard, Edward J. Walters
  • SUBLINGUAL EPINEPHRINE TABLETS
    Publication number: 20220133654
    Abstract: The present disclosure provides sublingual epinephrine tablets and methods of treating anaphylaxis, methods for concomitant therapy during a cardiac event, treating hypoglycemia, and prophylaxis for immunotherapy, using sublingual epinephrine tablets.
    Type: Application
    Filed: January 13, 2022
    Publication date: May 5, 2022
    Inventors: G. Lynn Howard, Nicholas J. Farina, Edward J. Walters, Christopher Howard
  • Sublingual epinephrine tablets
    Patent number: 11253488
    Abstract: The present disclosure provides sublingual epinephrine tablets and methods of treating anaphylaxis, methods for concomitant therapy during a cardiac event, treating hypoglycemia, and prophylaxis for immunotherapy, using sublingual epinephrine tablets.
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: February 22, 2022
    Assignee: pHase Pharmaceuticals LLC
    Inventors: G. Lynn Howard, Nicholas J. Farina, Edward J. Walters, Christopher Howard
  • Sublingual Epinephrine Tablets
    Publication number: 20190070131
    Abstract: The present disclosure provides sublingual epinephrine tablets and methods of treating anaphylaxis, methods for concomitant therapy during a cardiac event, treating hypoglycemia, and prophylaxis for immunotherapy, using sublingual epinephrine tablets.
    Type: Application
    Filed: August 28, 2018
    Publication date: March 7, 2019
    Inventors: G. Lynn Howard, Nicholas J. Farina, Edward J. Walters, Christopher Howard